Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Net Cash Flow (2020 - 2026)

Maxcyte has reported Net Cash Flow over the past 6 years, most recently at $7.1 million for Q4 2025.

  • Quarterly Net Cash Flow rose 178.16% to $7.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$7.8 million through Dec 2025, up 58.01% year-over-year, with the annual reading at -$7.8 million for FY2025, 58.01% up from the prior year.
  • Net Cash Flow was $7.1 million for Q4 2025 at Maxcyte, up from -$2.3 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $192.0 million in Q1 2022 and troughed at -$130.6 million in Q2 2022.
  • The 5-year median for Net Cash Flow is -$3.6 million (2023), against an average of $65460.0.
  • The largest YoY upside for Net Cash Flow was 225.15% in 2021 against a maximum downside of 409.24% in 2021.
  • A 5-year view of Net Cash Flow shows it stood at -$11.2 million in 2021, then crashed by 185.55% to -$32.0 million in 2022, then skyrocketed by 91.66% to -$2.7 million in 2023, then plummeted by 240.49% to -$9.1 million in 2024, then skyrocketed by 178.16% to $7.1 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Net Cash Flow are $7.1 million (Q4 2025), -$2.3 million (Q3 2025), and -$8.2 million (Q2 2025).